{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T05:09:53Z","timestamp":1779253793972,"version":"3.51.4"},"reference-count":19,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001350","name":"Ministry of Health -Singapore","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001350","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100022247","name":"Precision Health Research Singapore","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100022247","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001348","name":"Agency for Science, Technology and Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001348","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001352","name":"National University of Singapore","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001352","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100022902","name":"Saw Swee Hock School of Public Health, National University of Singapore","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100022902","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["atherosclerosis-journal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.atherosclerosis.2025.120416","type":"journal-article","created":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T08:54:04Z","timestamp":1752569644000},"page":"120416","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Cost-effectiveness of alternative cascade screening strategies for familial hypercholesterolemia with realistic cascade screening acceptance rates and use of novel treatment"],"prefix":"10.1016","volume":"415","author":[{"given":"Jing","family":"Lou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8593-7780","authenticated-orcid":false,"given":"Kok Joon","family":"Chong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sharon Li Ting","family":"Pek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasmin","family":"Bylstra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chester Lee","family":"Drum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weng Khong","family":"Lim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khung Keong","family":"Yeo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Subramaniam","family":"Tavintharan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hwee-Lin","family":"Wee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2025.120416_bib1","doi-asserted-by":"crossref","first-page":"8861","DOI":"10.1038\/s41598-018-27248-w","article-title":"Familial hypercholesterolemia in very young myocardial infarction","volume":"8","author":"Li","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.atherosclerosis.2025.120416_bib2","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.jacl.2020.12.012","article-title":"Prognostic impact of Cascade screening for familial hypercholesterolemia on cardiovascular events","volume":"15","author":"Tada","year":"2021","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.atherosclerosis.2025.120416_bib4","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.vhri.2020.09.001","article-title":"Health technology assessment in Australia: the pharmaceutical benefits advisory committee and medical services advisory committee","volume":"24","author":"Kim","year":"2021","journal-title":"Value Heal Reg Issues"},{"key":"10.1016\/j.atherosclerosis.2025.120416_bib6","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1017\/S0266462320000215","article-title":"The new definition of health technology assessment: a milestone in international collaboration","volume":"36","author":"O'Rourke","year":"2020","journal-title":"Int J Technol Assess Health Care"},{"key":"10.1016\/j.atherosclerosis.2025.120416_bib7","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s40273-023-01347-7","article-title":"Cost-effectiveness of screening strategies for familial hypercholesterolaemia: an updated systematic review","volume":"42","author":"Marquina","year":"2024","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.atherosclerosis.2025.120416_bib8","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1016\/j.jacl.2023.11.001","article-title":"A systematic review of cost-effectiveness analysis of different screening strategies for familial hypercholesterolemia","volume":"18","author":"Meng","year":"2024","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.atherosclerosis.2025.120416_bib9","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.atherosclerosis.2022.06.1011","article-title":"Familial hypercholesterolemia: a systematic review of modeling studies on screening interventions","volume":"355","author":"Jahn","year":"2022","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2025.120416_bib10","doi-asserted-by":"crossref","first-page":"25","DOI":"10.15605\/jafes.038.AFES.25","article-title":"Clinical characteristics and one-year treatment outcomes in a cohort of patients with familial hypercholesterolemia in Singapore: FHCARE registry","volume":"38","author":"Pek","year":"2023","journal-title":"J ASEAN Fed Endocr Soc"},{"key":"10.1016\/j.atherosclerosis.2025.120416_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/jcm9113489","article-title":"Familial hypercholesterolemia in premature acute coronary syndrome. Insights from cholestemi registry","volume":"9","author":"Lorca","year":"2020","journal-title":"J Clin Med"},{"key":"10.1016\/j.atherosclerosis.2025.120416_bib15","doi-asserted-by":"crossref","first-page":"3478","DOI":"10.1093\/eurheartj\/eht273","article-title":"Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease","volume":"34","author":"Nordestgaard","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.atherosclerosis.2025.120416_bib16","first-page":"111","article-title":"ESC\/EAS guidelines for the management of dyslipidaemias","author":"France","year":"2019","journal-title":"lipid modification to reduce cardiovascular risk 2020"},{"key":"10.1016\/j.atherosclerosis.2025.120416_bib17","article-title":"Familial hypercholesterolaemia: identification and management","year":"2019","journal-title":"Guidelines"},{"key":"10.1016\/j.atherosclerosis.2025.120416_bib18","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1194\/jlr.D400030-JLR200","article-title":"Multiplex ligation-dependent probe amplification of LDLR enhances molecular diagnosis of familial hypercholesterolemia","volume":"46","author":"Wang","year":"2005","journal-title":"J Lipid Res"},{"key":"10.1016\/j.atherosclerosis.2025.120416_bib20","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1007\/s40618-019-01019-4","article-title":"Effects of PCSK9 inhibitors on LDL cholesterol, cardiovascular morbidity and all-cause mortality: a systematic review and meta-analysis of randomized controlled trials","volume":"42","author":"Dicembrini","year":"2019","journal-title":"J Endocrinol Investig"},{"key":"10.1016\/j.atherosclerosis.2025.120416_bib21","first-page":"1545","article-title":"Population norms for the EQ-5D index scores using Singapore preference weights","volume":"24","author":"Abdin","year":"2015","journal-title":"Qual Life Res an Int J Qual Life Asp Treat Care Rehabil"},{"key":"10.1016\/j.atherosclerosis.2025.120416_bib23","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1016\/j.jacc.2016.03.520","article-title":"Diagnostic yield and clinical utility of sequencing familial hypercholesterolemia genes in patients with severe hypercholesterolemia","volume":"67","author":"Khera","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.atherosclerosis.2025.120416_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajpc.2021.100170","article-title":"A proof-of-concept study of Cascade screening for familial hypercholesterolemia in the US, adapted from the Dutch model","volume":"6","author":"McGowan","year":"2021","journal-title":"Am J Prev Cardiol"},{"key":"10.1016\/j.atherosclerosis.2025.120416_bib25","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0140-6736(00)03587-X","article-title":"Review of first 5 years of screening for familial hypercholesterolaemia in the Netherlands","volume":"357","author":"Umans-Eckenhausen","year":"2001","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.atherosclerosis.2025.120416_bib26","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1477-7525-8-13","article-title":"A review of health utilities using the EQ-5D in studies of cardiovascular disease","volume":"8","author":"Dyer","year":"2010","journal-title":"Health Qual Life Outcome"}],"updated-by":[{"DOI":"10.1016\/j.atherosclerosis.2025.120416","type":"removal","label":"Removal","source":"publisher","updated":{"date-parts":[[2025,7,12]],"date-time":"2025-07-12T00:00:00Z","timestamp":1752278400000}}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915025013140?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915025013140?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T04:38:39Z","timestamp":1779251919000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915025013140"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":19,"alternative-id":["S0021915025013140"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2025.120416","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cost-effectiveness of alternative cascade screening strategies for familial hypercholesterolemia with realistic cascade screening acceptance rates and use of novel treatment","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2025.120416","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"120416"}}